Biostar Pharmaceuticals Inc. logo

Biostar Pharmaceuticals Inc. (BSPM)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
264 Market Cap
- P/E Ratio
- Div Yield
150 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track BSPM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BSPM closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, BSPM stock gained 0%.
BSPM is not paying dividends to its shareholders.
The last earnings report, released on May 17, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Biostar Pharmaceuticals Inc. has completed 2 stock splits, with the recent split occurring on Feb 05, 2016.
The company's stock is traded on one exchange.

BSPM Chart

Biostar Pharmaceuticals Inc. (BSPM) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Biostar Pharmaceuticals Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BSPM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 264.

Has Biostar Pharmaceuticals Inc. ever had a stock split?

Biostar Pharmaceuticals Inc. had 2 splits and the recent split was on Feb 05, 2016.

Biostar Pharmaceuticals Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Rong Hua Wang CEO
OTC PINK Exchange
090678301 CUSIP
CN Country
200 Employees
- Last Dividend
4 Apr 2012 Last Split
- IPO Date

Overview

Biostar Pharmaceuticals, Inc. is a notable entity in the pharmaceutical industry, focusing on the development, manufacture, and marketing of both over-the-counter (OTC) and prescription pharmaceutical products. The company directs its efforts towards addressing various diseases and conditions predominantly in the People's Republic of China. Since its inception in 2007 and being headquartered in Xianyang, Biostar Pharmaceuticals has carved a niche in the Chinese healthcare market. It is especially recognized for its OTC medicine—Xin Ao Xing Oleanolic Acid capsule, widely used for chronic hepatitis B. Moreover, its strategic utilization of an online platform, serving as an Internet-based China Hepatitis Internet hospital, underscores its commitment to innovating the delivery of healthcare information and services. Through a comprehensive distribution network and a diligent sales force, the company ensures its presence across approximately 28 provinces in China.

Products and Services

Biostar Pharmaceuticals' product line is diversified across OTC items and prescription-based medications, catering to a wide spectrum of healthcare needs.

  • Xin Ao Xing Oleanolic Acid capsule: Serves as an OTC remedy for chronic hepatitis B, showcasing the company’s headliner product.
  • Ganwang compound paracetamol and amantadine hydrochloride capsule: Offers relief from common cold symptoms, including runny nose, sore throat, headache, and fever.
  • Tianqi Dysmenorrhea capsule: A traditional Chinese medicine utilized for alleviating pain and other symptoms associated with menstruation.
  • Deafness Tongqiao pills: Targeted for issues such as hepatobiliary Huosheng, head swelling, deafness and tinnitus, alongside providing relief for ear pus, dry stool, and urine-yellow conditions.
  • Wenweishu capsules: Focused on the treatment of chronic gastritis and the mitigation of epigastric cold pain.
  • Zhitongtougu ointment: Applied for the treatment of joint pain, swelling, tenderness, or dysfunction.
  • Chuzhang Zehaifu tablets: Developed for cataract conditions.
  • Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; Aspirin Enteric-coated tablets: These constitute the prescription pharmaceutical products segment, each addressing specific health concerns, from pediatric care to the management of conditions like hyperthyroidism and rhinitis.
  • Online Platform for Hepatitis B: Beyond tangible products, Biostar operates an online platform that functions as an Internet-based China Hepatitis Internet hospital. This innovative approach offers HBV patients access to indispensable information regarding HBV, treatment options, and facilitates the procurement of HBV medicines.

Contact Information

Address: No. 588 Shiji Xi Road
Phone: 86 29 3368 6638